Consistent with it, NCAPH was significantly co-expressed with PCNA (a specific marker for proliferation ability) in 308 cases of cervical cancer patients from the cBioportal database (Supplementary Fig. S3). This evidence concerns the gene PCNA and cervical carcinoma.